Bayesian adaptive design of early-phase clinical trials for precision medicine based on cancer biomarkers.

The International Journal of Biostatistics
Shinjo Yada

Abstract

Cancer tissue samples obtained via biopsy or surgery were examined for specific gene mutations by genetic testing to inform treatment. Precision medicine, which considers not only the cancer type and location, but also the genetic information, environment, and lifestyle of each patient, can be applied for disease prevention and treatment in individual patients. The number of patient-specific characteristics, including biomarkers, has been increasing with time; these characteristics are highly correlated with outcomes. The number of patients at the beginning of early-phase clinical trials is often limited. Moreover, it is challenging to estimate parameters of models that include baseline characteristics as covariates such as biomarkers. To overcome these issues and promote personalized medicine, we propose a dose-finding method that considers patient background characteristics, including biomarkers, using a model for phase I/II oncology trials. We built a Bayesian neural network with input variables of dose, biomarkers, and interactions between dose and biomarkers and output variables of efficacy outcomes for each patient. We trained the neural network to select the optimal dose based on all background characteristics of a patie...Continue Reading

References

Aug 1, 1993·Statistics in Medicine·D A Berry
Mar 26, 1999·Journal of Biopharmaceutical Statistics·J O'QuigleyA Gamst
Jul 6, 2001·Statistics in Medicine·J S Babb, A Rogatko
Aug 21, 2003·Biometrics·John O'Quigley, Xavier Paoletti
Oct 13, 2005·Statistics in Medicine·Anastasia Ivanova, Kai Wang
Nov 11, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Zhilong Yuan, Rick Chappell
Jun 13, 2006·Neural Computation·Geoffrey E HintonYee-Whye Teh
Nov 21, 2007·Journal of Biopharmaceutical Statistics·John WhiteheadAlvaro Pereira
Mar 22, 2008·Biometrics·Peter F ThallElihu H Estey
May 30, 2012·Oncology Reports·Sarah K MartinNatasha Kyprianou
Mar 21, 2015·PloS One·Kim Y C FungLeah J Cosgrove
Sep 1, 2015·Applied Immunohistochemistry & Molecular Morphology : AIMM·James E DavisMeenakshi Singh
Sep 18, 2015·Journal of the National Cancer Institute·Denis L JardimRazelle Kurzrock
Oct 17, 2015·Nature Reviews. Drug Discovery·Christopher-Paul MilneRanjana Chakravarthy
Jan 1, 2016·Journal of the American Statistical Association·Guanhua ChenMichael R Kosorok
Jul 6, 2017·The New England Journal of Medicine·Janet Woodcock, Lisa M LaVange
Nov 7, 2019·Biometrical Journal. Biometrische Zeitschrift·Pin LiMatthew J Schipper
Jan 1, 2017·Journal of the American Statistical Association·Beibei Guo, Ying Yuan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
Barbara K DunnPeter Greenwald
IDrugs : the Investigational Drugs Journal
Michael E SeverinoScott D Patterson
Clinical Trials : Journal of the Society for Clinical Trials
Nolan A Wages, Camilo E Fadul
© 2021 Meta ULC. All rights reserved